re: Ann: KarmelSonix Expands European Distrib... re: cashflow, thats definitely the major concern at the moment.
Of course being a small cap biotech you can't value it based on current cashflow the same way as a 'regular' stock. But before the money runs out we need to find an income stream. And like most hotcopperites the market has well and truly tapped me out this year re: SPP!!!!!!
